Nationwide epidemiology of early-onset sepsis in Israel 2010-2015, time to re-evaluate empiric treatment.
Daniel GlikmanNitzan CurielAharona Glatman-FreedmanOrli MeggedIlan YoungsterRonella MaromKaren LavieTatiana SmolkinMara TroitzkyMichal Steinnull nullPublished in: Acta paediatrica (Oslo, Norway : 1992) (2019)
In this nationwide study, EOS was caused predominantly by Gram-negatives, with high gentamicin resistance and ESBL phenotype rates, without identifiable resistance risk factors. As EOS is life-threatening, modification of empiric therapy for amikacin-based regimens should be considered, mainly in preterms.